Nature Communications · 2018 · 102 citations · 29 references
Life SciencesOncologyPharmacologyApoptosisAutophagyNanotechnologyAutophagy In CancerCancer MetabolismCancer NanomedicineCell-nanoparticle InteractionsMalignant NeoplasmsNanomedicineApoptosis Induction By NanoparticlesAutophagy Modulation By NanoparticlesCancer NanotherapyCancer-associated AutophagyCombination TherapyLiver Tumor TherapyMetabolic CouplingNanoparticle-based Chemotherapy
Arsenic trioxide (ATO) is a successful chemotherapeutic drug for blood cancers via selective induction of apoptosis; however its efficacy in solid tumors is limited. Here we repurpose nanodiamonds (NDs) as a safe and potent autophagic inhibitor to allosterically improve the therapeutic efficacy of ATO-based treatment in solid tumors. We find that NDs and ATO are physically separate and functionally target different cellular pathways (autophagy vs. apoptosis); whereas their metabolic coupling in human liver carcinoma cells remarkably enhances programmed cell death. Combination therapy in liver tumor mice model results in ~91% carcinoma decrease as compared with ~28% without NDs. Treated mice show 100% survival rate in 150 days with greatly reduced advanced liver carcinoma-associated symptoms, and ~80% of post-therapy mice survive for over 20 weeks. Our work presents a novel strategy to harness the power of nanoparticles to broaden the scope of ATO-based therapy and more generally to fight solid tumors.
29
Autophagy fights disease through cellular self-digestion
Noboru Mizushima, Beth Levine, Ana María Cuervo et al. · Nature · 2008 · 6.4K citations · Full text
Methods in Mammalian Autophagy Research
Noboru Mizushima, Tamotsu Yoshimori, Beth Levine · Cell · 2010 · 4.5K citations · Full text
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Ta-Chung Yu, Fangfang Guo, Yanan Yu et al. · Cell · 2017 · 2.2K citations · Full text